SNWV

SANUWAVE Health, Inc. [SNWV] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SNWV Stock Summary

Top 10 Correlated ETFs

SNWV


Top 10 Correlated Stocks

SNWV


In the News

04:30 28 Mar 2024 SNWV

SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results

EDEN PRAIRIE, MN, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, November 10, 2023, at 8:00AM (ET) to present the Q3 2023 financial results.

05:22 28 Mar 2024 SNWV

SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results

EDEN PRAIRIE, MN, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 11, 2023, at 8:30AM (EDT) to present its Q2 2023 financial results.

07:30 28 Mar 2024 SNWV

SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9:00 AM to Provide a Financial and Business Update

EDEN PRAIRIE, MN, May 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, May 12, 2023, at 9:00AM (EDT) to discuss a financial update and recent strategic initiatives.

10:24 28 Mar 2024 SNWV

SANUWAVE Will Host a Live Conference Call and Webcast April 3, 2023 at 9:00 AM to Provide a Financial and Business Update

Eden Prairie, MN, March 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Monday, April 3, 2023, at 9:00AM (EDT) to discuss a financial update and recent strategic initiatives.

08:00 28 Mar 2024 SNWV

SANUWAVE(R) to Present Thursday October 13th at the Microcap Rodeo Presents The Windy City Roundup 2022

EDEN PRAIRIE, MN / ACCESSWIRE / October 11, 2022 / SANUWAVE Health, Inc. (OTC PINK:SNWV), a leading provider of next-generation wound care products has been invited to present at the Microcap Rodeo presents The Windy City Roundup 2022 conference, which is being held live Wednesday and Thursday October 12th - 13th, 2022. SANUWAVE will present a live investor presentation on Thursday, October 13, 2022, at 10:30 AM (CT).

05:07 28 Mar 2024 SNWV

SANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update

Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via  NewMediaWire --  SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call on Tuesday, August 16, 2022, at 12:30 (EDT) to provide a business update (Dial-in information below).

07:30 28 Mar 2024 SNWV

SANUWAVE Health to Present at the Emerging Growth Conference on March 2, 2022

SANUWAVE invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference

11:05 28 Mar 2024 SNWV

SANUWAVE Health to Host Conference Call and Provide Business Update

SANUWAVE will hold a conference call on Wednesday, March 2, 2022 at 9:00 am ET

04:15 28 Mar 2024 SNWV

SANUWAVE Health, Inc. (SNWV) CEO Kevin Richardson on Business Update Call (Transcript)

SANUWAVE Health, Inc. (SNWV) CEO Kevin Richardson on Business Update Call (Transcript)

02:00 28 Mar 2024 SNWV

SANUWAVE Health to Host Conference Call and Provide Business Update

SANUWAVE will hold a conference call on Wednesday, January 19, 2022, at 9am ET to discuss its recent business activity

SNWV Financial details

Company Rating
Sell
Market Cap
22.53M
Income
-40.61M
Revenue
20.4M
Book val./share
-0.04
Cash/share
0
Dividend
-
Dividend %
-
Employees
38
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-0.32
Forward P/E
-
PEG
-0.01
P/S
1.29
P/B
-0.32
P/C
-
P/FCF
-3.8
Quick Ratio
0.05
Current Ratio
0.09
Debt / Equity
-0.73
LT Debt / Equity
-
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
1.57
EPS this Y
73.8%
EPS next Y
-
EPS next 5Y
-86.01%
EPS last 5Y
-11.66%
Revenue last 5Y
81.74%
Revenue Q/Q
41.21%
EPS Q/Q
-160.38%
-
-
-
-
SMA20
-33.33%
SMA50
-
SMA100
-
Inst Own
0.07%
Inst Trans
1.03%
ROA
-329%
ROE
121%
ROC
0.07%
Gross Margin
70%
Oper. Margin
-23%
Profit Margin
-354%
Payout
-
Shs Outstand
1.14B
Shs Float
1.08B
-
-
-
-
Target Price
-
52W Range
0.0046-0.044
52W High
-
52W Low
-
RSI
49.69
Rel Volume
1.67
Avg Volume
350.58K
Volume
585.9K
Perf Week
7.8%
Perf Month
7.8%
Perf Quarter
-5.85%
Perf Half Y
40.92%
-
-
-
-
Beta
1.007
-
-
Volatility
0%, 0%
Prev Close
5.17%
Price
0.02156
Change
2.67%

SNWV Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.010.010.030.030.03
Net income per share
-0.06-0.09-0.05-0.02-0.03
Operating cash flow per share
-0.03-0.03-0.01-0.03-0.01
Free cash flow per share
-0.03-0.03-0.01-0.03-0.01
Cash per share
0.010.01000
Book value per share
-0.05-0.04-0.08-0.07-0.05
Tangible book value per share
-0.05-0.07-0.1-0.1-0.06
Share holders equity per share
-0.05-0.04-0.08-0.07-0.05
Interest debt per share
0.040.050.060.10.06
Market cap
32.49M69.95M88.12M12.53M10.32M
Enterprise value
37.65M85.1M113.7M52.48M40.47M
P/E ratio
-2.65-2.05-3.23-1.22-0.4
Price to sales ratio
31.5817.246.770.750.51
POCF ratio
-5.07-5.5-13.75-0.73-2.27
PFCF ratio
-5.03-5.48-12.7-0.78-2.27
P/B Ratio
-3.23-5.1-2.26-0.31-0.24
PTB ratio
-3.23-5.1-2.26-0.31-0.24
EV to sales
36.620.978.743.131.98
Enterprise value over EBITDA
-4.32-5.19-6.9-4.5982.92
EV to operating cash flow
-5.87-6.69-17.74-3.06-8.92
EV to free cash flow
-5.82-6.66-16.39-3.25-8.92
Earnings yield
-0.38-0.49-0.31-0.82-2.5
Free cash flow yield
-0.2-0.18-0.08-1.29-0.44
Debt to equity
-0.69-1.28-0.67-1-0.73
Debt to assets
2.050.761.412.071.4
Net debt to EBITDA
-0.59-0.92-1.55-3.4961.78
Current ratio
0.20.220.080.110.15
Interest coverage
-4.79-7.09-1.99-0.63-0.03
Income quality
0.610.410.241.670.18
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
6.263.380.90.750.43
Research and developement to revenue
1.150.310.080.030.03
Intangibles to total assets
00.60.70.620.05
Capex to operating cash flow
0.0100.08-0.060
Capex to revenue
-0.05-0.01-0.040.060
Capex to depreciation
-0.76-0.05-0.431.070
Stock based compensation to revenue
0.320.010.22-0.03-0.03
Graham number
0.260.270.30.180.2
ROIC
4.33-4.221.14-16.770.05
Return on tangible assets
-3.63-3.7-4.94-1.38-1.21
Graham Net
-0.06-0.08-0.11-0.1-0.08
Working capital
-9.91M-28.25M-51.86M-53.57M-54.97M
Tangible asset value
-10.06M-27.52M-52.06M-53.41M-44.34M
Net current asset value
-10.94M-28.82M-53.18M-54.26M-55.81M
Invested capital
-0.69-1.28-0.67-1-0.73
Average receivables
155.77K1.22M2.39M3.22M3.67M
Average payables
1.52M2.95M6.05M6.02M5.05M
Average inventory
450.39K1.75M2M954K1.91M
Days sales outstanding
26.8211.8967.7587.8459.3
Days payables outstanding
974.881.4K559.58370.82306.81
Days of inventory on hand
367.73928.6176.1373.15158.7
Receivables turnover
13.621.725.394.166.16
Payables turnover
0.370.260.650.981.19
Inventory turnover
0.990.394.794.992.3
ROE
1.222.480.70.250.6
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.010.010.010.010.01
Net income per share
-0.01-0.05-0.01-0.030.02
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
-0.05-0.09-0.1-0.07-0.04
Tangible book value per share
-0.06-0.11-0.13-0.09-0.05
Share holders equity per share
-0.05-0.09-0.1-0.07-0.04
Interest debt per share
0.050.080.090.040.03
Market cap
19.88M24.15M13.22M18.84M14.83M
Enterprise value
59.83M63.99M58.27M55.66M44.97M
P/E ratio
-0.61-0.22-0.46-0.20.2
Price to sales ratio
3.616.42.833.82.12
POCF ratio
-4.98-65.1-15.66-9.25-11.54
PFCF ratio
-6.69-62.09-13.29-9.25-13.29
P/B Ratio
-0.48-0.45-0.22-0.29-0.34
PTB ratio
-0.48-0.45-0.22-0.29-0.34
EV to sales
10.8816.9512.4611.246.43
Enterprise value over EBITDA
-21.8-36.6551.71-354.5234.95
EV to operating cash flow
-14.98-172.49-69.04-27.31-35
EV to free cash flow
-20.14-164.5-58.56-27.31-40.3
Earnings yield
-0.41-1.15-0.55-1.261.23
Free cash flow yield
-0.15-0.02-0.08-0.11-0.08
Debt to equity
-1-0.74-0.75-0.57-0.73
Debt to assets
2.072.282.361.861.4
Net debt to EBITDA
-14.55-22.8239.98-234.5123.42
Current ratio
0.110.060.080.090.15
Interest coverage
-0.69-0.460.210.120.33
Income quality
0.490.030.120.09-0.07
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.740.730.260.540.29
Research and developement to revenue
0.010.030.030.030.02
Intangibles to total assets
0.620.70.630.580.05
Capex to operating cash flow
-0.260.050.180-0.13
Capex to revenue
0.190-0.0300.02
Capex to depreciation
3.77-0.07-0.5900.68
Stock based compensation to revenue
-0.0900.050-0.03
Graham number
0.10.320.170.210.12
ROIC
-5.650.31-0.10.01-0.09
Return on tangible assets
-1.09-5.29-1.02-2.80.86
Graham Net
-0.06-0.12-0.13-0.09-0.05
Working capital
-53.57M-66.13M-73.18M-78.04M-54.97M
Tangible asset value
-53.41M-66.01M-72.88M-77.82M-44.34M
Net current asset value
-54.26M-66.77M-73.93M-78.9M-55.81M
Invested capital
-1-0.74-0.75-0.57-0.73
Average receivables
3.22M3.5M2.89M3.02M3.27M
Average payables
4.73M4.83M5.06M4.74M5.16M
Average inventory
1.14M969.5K985.5K1.31M2.33M
Days sales outstanding
65.9370.7854.2558.7142.65
Days payables outstanding
227.46375.4363.82294.67218.68
Days of inventory on hand
44.8776.3867.39109.19113.11
Receivables turnover
1.371.271.661.532.11
Payables turnover
0.40.240.250.310.41
Inventory turnover
2.011.181.340.820.8
ROE
0.20.520.120.36-0.42
Capex per share
00000

SNWV Frequently Asked Questions

What is SANUWAVE Health, Inc. stock symbol ?

SANUWAVE Health, Inc. is a US stock , located in Suwanee of Ga and trading under the symbol SNWV

What is SANUWAVE Health, Inc. stock quote today ?

SANUWAVE Health, Inc. stock price is $0.02156 today.

Is SANUWAVE Health, Inc. stock public?

Yes, SANUWAVE Health, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap